BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 8445198)

  • 1. Secondary injury mechanisms in acute spinal cord injury.
    Young W
    J Emerg Med; 1993; 11 Suppl 1():13-22. PubMed ID: 8445198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study.
    Bracken MB; Shepard MJ; Collins WF; Holford TR; Young W; Baskin DS; Eisenberg HM; Flamm E; Leo-Summers L; Maroon J
    N Engl J Med; 1990 May; 322(20):1405-11. PubMed ID: 2278545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological treatment of acute spinal cord injury: current status and future projects.
    Bracken MB
    J Emerg Med; 1993; 11 Suppl 1():43-8. PubMed ID: 8445202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic strategies in the treatment of experimental spinal cord injury.
    Nockels R; Young W
    J Neurotrauma; 1992 Mar; 9 Suppl 1():S211-7. PubMed ID: 1588610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose methylprednisolone may do more harm for spinal cord injury.
    Qian T; Campagnolo D; Kirshblum S
    Med Hypotheses; 2000 Nov; 55(5):452-3. PubMed ID: 11058428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. End organ effects of high-dose human equivalent methylprednisolone in a spinal cord injury rat model.
    Kubeck JP; Merola A; Mathur S; Brkaric M; Majid K; Shanti N; Caruso S; Yuan S; Lowe T; Dwyer A; Haher T; O'Brien M
    Spine (Phila Pa 1976); 2006 Feb; 31(3):257-61. PubMed ID: 16449896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent effects of naloxone and methylprednisolone in the ventral compression model of spinal cord injury.
    Benzel EC; Hoffpauir GM; Thomas MM; Beal JA; Lancon JA; Kesterson L
    J Spinal Disord; 1990 Dec; 3(4):339-44. PubMed ID: 2134448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GM-1 ganglioside and motor recovery following human spinal cord injury.
    Geisler FH
    J Emerg Med; 1993; 11 Suppl 1():49-55. PubMed ID: 8445203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of acute spinal cord injury with methylprednisolone: results of a multicenter, randomized clinical trial.
    Bracken MB
    J Neurotrauma; 1991 Jul; 8 Suppl 1():S47-50; discussion S51-2. PubMed ID: 1920461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylprednisolone after spinal cord injury.
    Segatore M; Way C
    SCI Nurs; 1993 Mar; 10(1):8-14. PubMed ID: 8484108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological therapy of acute spinal cord injury: studies of high dose methylprednisolone and naloxone.
    Young W; DeCrescito V; Flamm ES; Blight AR; Gruner JA
    Clin Neurosurg; 1988; 34():675-97. PubMed ID: 3378379
    [No Abstract]   [Full Text] [Related]  

  • 12. Use and determinants of the methylprednisolone protocol for traumatic spinal cord injury in South Carolina acute care hospitals.
    Nicholas JS; Selassie AW; Lineberry LA; Pickelsimer EE; Haines SJ
    J Trauma; 2009 May; 66(5):1446-50; discussion 1450. PubMed ID: 19430253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urgent surgical decompression compared to methylprednisolone for the treatment of acute spinal cord injury: a randomized prospective study in beagle dogs.
    Rabinowitz RS; Eck JC; Harper CM; Larson DR; Jimenez MA; Parisi JE; Friedman JA; Yaszemski MJ; Currier BL
    Spine (Phila Pa 1976); 2008 Oct; 33(21):2260-8. PubMed ID: 18827690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The biochemical effectiveness of N-acetylcysteine in experimental spinal cord injury in rats.
    Hanci V; Kerimoğlu A; Koca K; Başkesen A; Kiliç K; Taştekin D
    Ulus Travma Acil Cerrahi Derg; 2010 Jan; 16(1):15-21. PubMed ID: 20209390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose methylprednisolone in the treatment of spinal cord injuries.
    Hilton G; Frei J
    Heart Lung; 1991 Nov; 20(6):675-80. PubMed ID: 1960072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of timing of methylprednisolone or naloxone administration on recovery of segmental and long-tract neurological function in NASCIS 2.
    Bracken MB; Holford TR
    J Neurosurg; 1993 Oct; 79(4):500-7. PubMed ID: 8410217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological and functional status 1 year after acute spinal cord injury: estimates of functional recovery in National Acute Spinal Cord Injury Study II from results modeled in National Acute Spinal Cord Injury Study III.
    Bracken MB; Holford TR
    J Neurosurg; 2002 Apr; 96(3 Suppl):259-66. PubMed ID: 11990832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does high dose methylprednisolone sodium succinate really improve neurological status in patient with acute cervical cord injury?: a prospective study about neurological recovery and early complications.
    Ito Y; Sugimoto Y; Tomioka M; Kai N; Tanaka M
    Spine (Phila Pa 1976); 2009 Sep; 34(20):2121-4. PubMed ID: 19713878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of methylprednisolone, naloxone, and spinal cord trauma on four liver enzymes: observations from NASCIS 2. National Acute Spinal Cord Injury Study.
    Shepard MJ; Bracken MB
    Paraplegia; 1994 Apr; 32(4):236-45. PubMed ID: 8022633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological treatment of acute spinal cord injury: current status and future prospects.
    Bracken MB
    Paraplegia; 1992 Feb; 30(2):102-7. PubMed ID: 1589282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.